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Do Enzymatic Analyses of Serum Triglycerides Really Need Blanking for Free Glycerol?
Robert H. Jessen, CindyJ. Dass, and John H. Eckteidt'
Distributions of concentrations of free glycerol in clinical plasma obtained for triglyceride assay were compiled to determine the frequency with which increased concentrations of free glycerol posed a potential problem for clinical interpretation of triglyceride results. Clinical histories were studied in patients with increased concentrations of free glycerol to ascertain possible reasons for the increase and to assess the relative clinical importance of glycerol-blankcorrected triglyceride results. Significant increases in free glycerol were very uncommon, usually occurring in patients receiving glycerol-containing hyperalimentation fluids, those receiving heparin (which causes both in vivo and in vitro increases in free glycerol), or those critically ill. Free glycerol was never increased significantly in a large outpatient population. Monitoring lipid metabolism in critically ill patients, or measuring true triglyceride concentrations in patients receiving glycerol-containing fluids, may represent rare exceptions for which glycerol-blank correction is necessary for accurate clinical diagnosis and management.
We conclude that there is insufficient justification for the routine expenditure of extra time and reagents to correct most analytical enzymatic triglyceride methods for free glycerol. We measured concentrations of triglyceride and free glycerol in 419 inpatient samples and in 339 outpatient samples from two clinics, one a heart-disease prevention clinic and the other an adult medicine clinic, for which triglyceride analysis was requested over a four-week period. We then reviewed the clinical history and hospital course of 20 inpatients whose concentrations of free glycerol exceeded 0.28 mmol/L, to discover possible clinical explanations for the increased free glycerol and to evaluate the clinical relevance of an accurate triglyceride determination in these patients. We specifically sought evidence for previously reported causes of increased free glycerol, e.g., liver disease, diabetes mellitus, hemodialysis, severe stress, and administration of intravenous medications in a glycerol carrier (1). In addition, because the lipid emulsion used at our institution for parenteral nutrition (Intralipid; KabiVitrurn, Inc., Alameda, CA 94501) contains glycerol at 244 mmoIJL, we sought a history of its administration.
Heparmn administration causes release of endogenous lipases and consequently in vivo triglyceride hydrolysis. A recent report showed that this hydrolysis continues in vitro (4). To estimate the relative magnitude of the in vivo and in vitro hydrolysis in routinely handled clinical specimens, we administered 5500 USP units of heparmn intravenously to an apparently healthy volunteer, and collected EDTAanticoagulated blood samples from him over the next 80 mm. Blood specimens were centrifuged without delay, and the separated plasma was divided into six parts. One plasma aliquot was immediately frozen on solid CO2; the others were allowed to stand at approximately 23 #{176}C for 30, 60, 120, 240, and 360 mm, after which they were also frozen. All samples were thawed -24 h later and, without delay, were analyzed for free glycerol and total triglyceride by the methods described above.
Results
The frequency distributions for free glycerol in our inpatient and outpatient populations are shown in Figure 1 . All of our outpatient samples had glycerol-blank values <0.28 mmolIL; in fact, 99% were <0.10 mmol/L. In our inpatients, 97% had <0.28 mmol/L, with the remainder being quite variable. Figure 2 shows the frequency distributions for the potential error in triglyceride concentration that would result if the glycerol blanks were not subtracted.
With no free-glycerol blanking for outpatients, 96% would have <10% false increase in triglyceride concentration and 99% would have <15% false increase. With no free-glycerol blanking for inpatients, 88% would have <10% false increase in triglyceride concentration, 92% would have <15% false increase, and 95% would have <20% false increase. The remaining 5% of inpatients showed highly variable false increases. Although statistically significant (t = 3.97, P <0.001), we found no clinically useful relationship (r = 0.14) between the concentration of free glycerol and total triglyceride, in contrast to a previous report (5). Table 1 In the third patient, the increased free glycerol was attributed to an epinephrime effect, as this patient had severe postsurgical complications and infection. Figure 3 shows the results of the intravenous heparin study. For this subject the baseline concentration of triglyceride in plasma was -2.15 mmol/L and the free glycerol was only 0.03 mmolJL before heparmn administration. The points on the ordinate of Figure 3 show that intravenous administration of heparin causes a very rapid, but relatively short-lived, in vivo increase in free glycerol. In this particular experiment, free glycerol peaked at 0.42 mmolJL at 24 mm and fell gradually to -0.18 mmol/L at 85 mm post-heparin administration. Figure 3 also demonstrates the significant in vitro rise in free glycerol and the decrease in triglycerides when plasma from a heparmn-treated subject is allowed to stand at room temperature for even a few hours. (2) . Evaluation of the distribution of concentrations of free glycerol in our patient population reveals that under most circumstances the vast majority are not of sufficient magnitude to introduce a significant, clinically meaningful error. In outpatients, most triglyceride requests are part of a lipid profile to allow for calculation of low-density lipoprotein cholesterol and evaluation of combined hyperlipidemias as part of a coronary vascular disease risk assessment (7, 8) . Failure to glycerol-blank the reported triglyceride result would have introduced an erro of >0.11 mmollL in fewer than 1% of our outpatients, and never would have produced an error of >0.28 mmolJL. Errors of this magnitude are relatively insignificant cmi cally for lipid proffling.
Triglycerides are also occasionally requested for screen ing for coronary risk inpatients, in which group we sa increased free glycerol much more often; however, thi practice should be discouraged because no baseline lipit status had been established for these patients during hos pitalization.
Other inpatient triglyceride requests are fo: metabolic monitoring of critically ill patients, many o whom are receiving intravenous nutritional support. A shown in Table 1 Figure 3 shows that heparin induces rapid hydrolysis of triglycerides both in vivo and in vitro. Subtraction of free glycerol from the unblanked triglyceride in such a situation would actually lead to underestimation of the subject's true baseline triglyceride.
In fact, the in vitro glycerol production often more than doubles the actual in vivo glycerol concentration. Because glycerol is cleared from the plasma rapidly with a half-life of approximately 40 mm (10), neither a glycerol-blanked nor an unblanked triglyceride result will accurately reflect a subject's baseline, pre-heparmn triglyceride concentration. In our opinion, this combined in vivo and in vitro hydrolysis by heparin usually makes triglyceride measurements in patients receiving heparin clinically uninterpretable. Interpretable results can be obtained if one very rapidly freezes the plasma, within minutes of blood collection, or adds lipase inhibitors to the collection tube. These conditions are almost never met routinely in most inpatient critical-care units.
The results of this study suggest that routine correction of triglyceride assays for free glycerol is difficult to justify if additional cost or technical effort is involved. Critically ill patients such as those discussed above clearly represent a group that may have increased concentrations of free glycerol and in which glycerol blanking may be appropriate. Although easily recognized clinically, this group of patients may not be easily recognized by the laboratory. The effect of heparin on free-glycerol blanks demonstrates the complexity of clinical interpretation, even when glycerol blanking is performed. In the critically ill patient with complications, interpretation of triglyceride concentrations as a metabolic indicator requires a clinician's complete understanding of all the clinical and analytical variables that ultimately influence the test results. We believe that providing for glycerol-blank correction of triglyceride determination only upon specific request, as we have chosen to offer in our hospital, facilitates the necessary communication between the laboratorian and the clinician. Furthermore, it eliminates the unnecessary practice of routinely measuring a glycerol blank on all samples, the vast majority of which do not need it.
As discussed previously, to measure triglycerides without interference from free glycerol, most clinical analyzers must measure glycerol in a separate reaction cuvette.
However, this requires increased time, reagents, and supplies. An alternative solution to the glycerol interference problem that has recently been introduced commercially is use of a reagent designed for instruments capable of a delayed addition of a second reagent (i.e., lipase). This method first preincubates the sample with reagent to consume the preformed glycerol. Although this represents a more economical solution to the free-glycerol interference, it cannot be applied to many of the analyzers in use in clinical laboratories. Consequently, most laboratories do not perform glycerol blanks (2) .
In summary, we believe that the performance of routine glycerol blanks is clinically unnecessary under most circumstances and, depending on the analyzers a laboratory has available, may not be justifiable economically. Specimens from outpatients do not need glycerol blanking. However, for inpatients there are special, infrequent situations for which measurement of free glycerol along with triglycerides is useful. We believe that glycerol blanking is best performed after some formal communication between the clinician and the clinical laboratory to facilitate accurate interpretation of the results.
